Pathologists at the Stanford University School of Medicine are trying out a new test from a Sunnyvale company that could give cancer patients a better chance of getting the most effective treatment.

Life Technologies acquired Pinpoint Genomics and its early-stage non-small-cell lung cancer test. The test is designed to identify early-stage patients at high risk for progression to late-stage ...

(MENAFN- Mid-East Info) A pioneering AI-enabled multi-cancer blood test, developed with the NHS in England, will be among the headline innovations featured on the UK Pavilion at WHX Dubai 2026, as UK ...